North American breast cancer diagnostics and therapeutics market are estimated to grow significantly at a CAGR of 9.6% during the forecast period. The major factors that augment market growth such as rising awareness programs from government & private organizations, the introduction of new technologies such as 3D mammography and high expenditure on breast cancer therapies and medicines.